1. Home
  2. WKHS vs RGNT Comparison

WKHS vs RGNT Comparison

Compare WKHS & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workhorse Group Inc.

WKHS

Workhorse Group Inc.

HOLD

Current Price

$2.58

Market Cap

17.4M

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.11

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WKHS
RGNT
Founded
2007
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4M
20.4M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
WKHS
RGNT
Price
$2.58
$3.11
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$21.00
N/A
AVG Volume (30 Days)
76.8K
3.3K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
86.92
N/A
EPS
N/A
N/A
Revenue
$763,173.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.53
$2.80
52 Week High
$11.80
$8.35

Technical Indicators

Market Signals
Indicator
WKHS
RGNT
Relative Strength Index (RSI) 30.20 38.57
Support Level $0.92 $2.80
Resistance Level $3.60 $3.38
Average True Range (ATR) 0.22 0.16
MACD -0.02 0.08
Stochastic Oscillator 10.34 53.44

Price Performance

Historical Comparison
WKHS
RGNT

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: